Document
MYDAYIS, 022063, Letter (Orange Book Jun. 20, 2017)
Cite Document
MYDAYIS, 022063, Letter (Orange Book Jun. 20, 2017)
+ More Snippets
Document
MYDAYIS, 022063, Review Proprietary Name Reviews (Orange Book Jun. 20, 2017)
Cite Document
MYDAYIS, 022063, Review Proprietary Name Reviews (Orange Book Jun. 20, 2017)
+ More Snippets
Document
MYDAYIS, 022063, Review Other Reviews (Orange Book Jun. 20, 2017)
Cite Document
MYDAYIS, 022063, Review Other Reviews (Orange Book Jun. 20, 2017)
+ More Snippets
Document
MYDAYIS, 022063, Review Printed Labeling (Orange Book Jun. 20, 2017)
Cite Document
MYDAYIS, 022063, Review Printed Labeling (Orange Book Jun. 20, 2017)
+ More Snippets
Document
MYDAYIS, 022063, Review Clinical Pharmacology Biopharmaceutics Reviews (Orange Book Jun. 20, 2017)
Cite Document
MYDAYIS, 022063, Review Clinical Pharmacology Biopharmaceutics Reviews (Orange Book Jun. 20, 2017)
+ More Snippets
Document
MYDAYIS, 022063, Review Medical Reviews (Orange Book Jun. 20, 2017)
Cite Document
MYDAYIS, 022063, Review Medical Reviews (Orange Book Jun. 20, 2017)
+ More Snippets
Document
MYDAYIS, 022063, Review Other Action Letters (Orange Book Jun. 20, 2017)
Cite Document
MYDAYIS, 022063, Review Other Action Letters (Orange Book Jun. 20, 2017)
+ More Snippets
Document
MYDAYIS, 022063, Review Chemistry Reviews (Orange Book Jun. 20, 2017)
Cite Document
MYDAYIS, 022063, Review Chemistry Reviews (Orange Book Jun. 20, 2017)
+ More Snippets
Document
IPR2018-00290, No. 2049-94 Exhibit - Gibaldi, Biopharmaceutics Clinical Pharmacokinetics, Appendix II Superposition 1991 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00290, No. 2049-94 Exhibit - Gibaldi, Biopharmaceutics Clinical Pharmacokinetics, Appendix II Superposition 1991 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00290, No. 1032-33 Exhibit - 1032 Adderall IR Label 2005 (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2018-00290, No. 1032-33 Exhibit - 1032 Adderall IR Label 2005 (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2018-00290, No. 1038-39 Exhibit - 1038 Wilson in oral Drug Administration Prediction and Assessment 2000 (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2018-00290, No. 1038-39 Exhibit - 1038 Wilson in oral Drug Administration Prediction and Assessment 2000 (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2018-00290, No. 1013-14 Exhibit - 1013 DrugsFDA Adderall XR (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2018-00290, No. 1013-14 Exhibit - 1013 DrugsFDA Adderall XR (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2018-00290, No. 1010-11 Exhibit - 1010 Kratochvil XR1 (P.T.A.B. Dec. 11, 2017)
Cite Document
IPR2018-00290, No. 1010-11 Exhibit - 1010 Kratochvil XR1 (P.T.A.B. Dec. 11, 2017)
+ More Snippets
Document
IPR2018-00290, No. 2018-63 Exhibit - USP 23 NF 18 1995 Excerpts 1955 Part 2 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00290, No. 2018-63 Exhibit - USP 23 NF 18 1995 Excerpts 1955 Part 2 (P.T.A.B. Apr. 10, 2018)
+ More Snippets
Document
IPR2018-00290, No. 2013-57 Exhibit - Porter, Remington, Ch 93 Coating 1995 (P.T.A.B. Apr. 10, 2018)
Cite Document
IPR2018-00290, No. 2013-57 Exhibit - Porter, Remington, Ch 93 Coating 1995 (P.T.A.B. Apr. 10, 2018)
+ More Snippets